NCT00544219 PET Scans in Patients With Diffuse Large B-Cell Lymphoma Receiving Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Status COMPLETED Phase NA
NCT00541281 Safety and Efficacy Study of of Docetaxel vs Docetaxel Estramustine in Hormone Refractory Prostatic Cancer Status COMPLETED Phase PHASE2
NCT00540644 Phase II Study of Revlimid®, Oral Cyclophosphamide and Prednisone for Patients With Newly Diagnosed Multiple Myeloma Status COMPLETED Phase PHASE2
NCT00539838 A Study to Evaluate Two Doses of Ocrelizumab in Patients With Active Systemic Lupus Erythematosus (BEGIN) Status TERMINATED Phase PHASE3
NCT00537381 An Efficacy and Safety Study of Intetumumab (CNTO 95) in Participants With Metastatic Hormone Refractory Prostate Cancer Status COMPLETED Phase PHASE2
NCT00527124 Docetaxel and Prednisone With or Without Cediranib in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy Status TERMINATED Phase PHASE2
NCT00526305 LAL-Ph-2000: Treatment of Acute Lymphoblastic Leukemia Chromosome Philadelphia Positive Status COMPLETED Phase PHASE4
NCT00520468 Treatment of Myelodysplastic Syndrome (MDS) With Cytokine-Immunotherapy for Low-Risk MDS Status COMPLETED Phase PHASE2
NCT00514267 An Open-Label Study of YM155 + Docetaxel in Subjects With Advanced Hormone Refractory Prostate Cancer and Other Solid Tumors Status COMPLETED Phase PHASE1/PHASE2
NCT00513188 Combination Chemotherapy and Denileukin Diftitox in Treating Patients With Newly Diagnosed T-Cell Non-Hodgkin Lymphoma Status WITHDRAWN Phase NA
NCT00508040 Evaluation of Birdshot Retine Choroidopathy Treatment by Either Steroid or Interferon alpha2a Status COMPLETED Phase PHASE2
NCT00507416 Velcade,Thalidomide, and Dexamethasone Versus Velcade and Dexamethasone Versus Velcade, Melphalan, and Prednisone Status COMPLETED Phase PHASE3
NCT00503984 A Phase I/II Study of Azacitidine, Docetaxel, and Prednisone for Metastatic Prostate Cancer Patients Status TERMINATED Phase PHASE1/PHASE2
NCT00501826 Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma Status RECRUITING Phase PHASE2
NCT00499018 Dose Dense Chemotherapy + Rituximab +/-Intensified High Dose Chemoimmunotherapy With Support of Peripheral Autologous Stem Cell in Diffuse Large B-Cell Lymphoma Status UNKNOWN Phase PHASE3
NCT00494897 PETHEMA LAL-RI/96: Treatment for Patients With Standard Risk Acute Lymphoblastic Leukemia Status COMPLETED Phase PHASE4
NCT00486421 Rituximab and Prednisone as First-Line Therapy in Treating Patients With Immune Thrombocytopenic Purpura Status COMPLETED Phase EARLY_PHASE1
NCT00485303 An Efficacy and Safety Study of Abiraterone Acetate and Prednisone in Participants With Prostate Cancer Who Failed Androgen Deprivation and Docetaxel-Based Chemotherapy Status COMPLETED Phase PHASE2